The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1079
ISSUE1079
May 29, 2000
Linezolid (Zyvox)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Linezolid (Zyvox)
May 29, 2000 (Issue: 1079)
Linezolid, the first of a new class of antibiotics, the oxazolidinones, has been marketed for treatment of infection due to vancomycin-resistant Enterococcus faecium, nosocomial and community-acquired pueumonia due to Staphylococcus aureus or...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.